drugset / Trial / NCT02740868

Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease

NCT02740868

Phase 2 Recruiting 30 enrolled The Hospital for Sick Children
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

Aim of this study is to evaluate image quality and reproducibility of Xenon-129 and Inert fluorinated (19F) gas Magnetic Resonance Imaging (MRI) and to evaluate changes in lung structure and function in participants with cystic fibrosis (CF) and asthma compared to healthy controls.

Timeline

Start
2015-08
Primary completion
2026-12-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Definity Diagnostic / imaging agent Inhaled
Comparator Xenon-129 Diagnostic / imaging agent Inhaled

Indications